Difference between revisions of "Mixed germ cell tumour"
Jump to navigation
Jump to search
m (→IHC) |
(→IHC) |
||
Line 66: | Line 66: | ||
A panel: | A panel: | ||
*PLAP. | *PLAP. | ||
*CD30 - [[embryonal carcinoma]]. | *CD30 +ve -- [[embryonal carcinoma]]. | ||
*CD117 - seminoma. | *CD117 +ve -- [[seminoma]]. | ||
*D2-40 - seminoma | *D2-40 +ve -- seminoma, useful for [[LVI]]. | ||
*Pankeratin - embryonal carcinoma. | *Pankeratin +ve -- embryonal carcinoma. | ||
*CEA-M. | *CEA-M. | ||
*EMA. | *EMA +ve -- metastatic carcinoma.<ref>{{Cite journal | last1 = Shek | first1 = TW. | last2 = Yuen | first2 = ST. | last3 = Luk | first3 = IS. | last4 = Wong | first4 = MP. | title = Germ cell tumour as a diagnostic pitfall of metastatic carcinoma. | journal = J Clin Pathol | volume = 49 | issue = 3 | pages = 223-5 | month = Mar | year = 1996 | doi = | PMID = 8675733 }}</ref> | ||
*Vimentin. | *Vimentin. | ||
*AFP - [[yolk sac tumour]]. | *AFP +ve -- [[yolk sac tumour]]. | ||
*A1A - yolk sac tumour. | *A1A +ve -- yolk sac tumour. | ||
==See also== | ==See also== |
Revision as of 13:14, 8 January 2014
Mixed germ cell tumour | |
---|---|
Diagnosis in short | |
Mixed germ cell tumour. H&E stain. | |
| |
LM | depends on the components |
LM DDx | other germ cell tumours |
IHC | variable |
Site | ovary, testis, mediastinum, other |
| |
Signs | mass lesion |
Prevalence | most common germ cell tumour |
Blood work | +/-AFP elevated, +/-beta-hCG elevated, +/-LDH elevated |
Prognosis | worse than seminoma/dysgerminoma |
Clin. DDx | gonads: germ cell tumours, other tumours |
Mixed germ cell tumour, abbreviated MGCT, is a lesion composed of different germ cell tumours. Most germ cell tumours are mixed.
General
- 60% of GCTs are mixed. †
Common combinations:
- Teratoma + embryonal carcinoma + endodermal sinus tumour (yolk sac tumour) (TEE).
- Seminoma + embryonal (SE).
- Teratoma + embryonal +(TE).
Memory device: TEE + all combinations have embryonal carcinoma.
Note:
- † Numbers vary between sources. One series suggests it is almost 70%.[1]
- There has been in increase in MGCTs over the past 20 years that is probably due to changes how in how GCTs are classified.[2]
Microscopic
Features:
- Depends on components.
Notes:
- If one cannot identify the component... it is probably yolk sac as this has so many different patterns.
Images
www:
- Mixed germ cell tumour - several images (upmc.edu).
- Mixed germ cell tumour - several cases (upmc.edu).
IHC
- Beta-hCG +ve - if syncytiotrophoblasts are present.
- AFP +ve - a yolk sac tumour component is present.
- GFAP +ve - if neuroepithelium is present.
A panel:
- PLAP.
- CD30 +ve -- embryonal carcinoma.
- CD117 +ve -- seminoma.
- D2-40 +ve -- seminoma, useful for LVI.
- Pankeratin +ve -- embryonal carcinoma.
- CEA-M.
- EMA +ve -- metastatic carcinoma.[3]
- Vimentin.
- AFP +ve -- yolk sac tumour.
- A1A +ve -- yolk sac tumour.
See also
References
- ↑ Mosharafa, AA.; Foster, RS.; Leibovich, BC.; Ulbright, TM.; Bihrle, R.; Einhorn, LH.; Donohue, JP. (Apr 2004). "Histology in mixed germ cell tumors. Is there a favorite pairing?". J Urol 171 (4): 1471-3. doi:10.1097/01.ju.0000116841.30826.85. PMID 15017200.
- ↑ Trabert, B.; Stang, A.; Cook, MB.; Rusner, C.; McGlynn, KA. (Aug 2011). "Impact of classification of mixed germ-cell tumours on incidence trends of non-seminoma.". Int J Androl 34 (4 Pt 2): e274-7. doi:10.1111/j.1365-2605.2011.01187.x. PMID 21623833.
- ↑ Shek, TW.; Yuen, ST.; Luk, IS.; Wong, MP. (Mar 1996). "Germ cell tumour as a diagnostic pitfall of metastatic carcinoma.". J Clin Pathol 49 (3): 223-5. PMID 8675733.